QinetiQ Sells America to Buy Britain
A GBP 175m impairment, a Serco cheque and a GBP 200m buyback later, QinetiQ is betting its entire story on European rearmament — just as the tape has stopped paying for it.
QQ.L · Earnings Call · 2026-11-12
The disposal is the strategy
For three quarters the American question hung over these calls like a smell. In May, Steve Wadey would only say the group was going to “look at the business and assess that fit and look at the long-term return and value creation for shareholders” — Steve Wadey, Chief Executive Officer · 2026-05-21. On Thursday he answered it: the U.S. business goes to Serco, expected to complete in Q1 2027, against a GBP 175m non-cash impairment on the carrying value. The U.S. sale is not a tidying-up exercise; it is the strategy. The logic, stated bluntly: “whilst we have a smaller, better business, we do not have the scale to meet our growth and returns expectations relative to the rest of our portfolio” — Steve Wadey, Chief Executive Officer · 2026-11-12. This is the second act of a retreat that began quietly. The Fed IT divestment was flagged as a fresh theme back in the third quarter of 2025; what nobody priced then was that the rest of the U.S. platform — the Avantus acquisition that was supposed to be the growth engine — would follow it out of the door two years later. What remains is a different animal. Post-completion, revenue from sole source and long-term contracts rises to 70%, and the CEO leans hard on that number when an analyst needles him about hubris: “That's why 70% of our revenue is on single source long-term contracts. That's a high-quality business that is very predictable.” — Steve Wadey, Chief Executive Officer · 2026-11-12 He is not wrong. He is, however, describing an annuity, not a growth company — and the rest of the call is a struggle over which of the two the market should be paying for.Smaller, more political, and newly armed
The half itself was unremarkable in the best sense. Revenue +3% to GBP 923m, underlying operating profit +14% to GBP 110m at an 11.9% margin, order intake +9%, operating cash flow GBP 113m, net debt GBP 274m at 0.8x. Strip out the U.S. and the core grew 5%. ROCE of 41% is the flattering residue of portfolio surgery rather than operating genius. The more interesting detail is what the residue looks like. Global Solutions — the segment that topped this company's keyword table back in 2023 — survives as roughly GBP 100m of revenue at something north of 15% margins, built on aerial and maritime targets and a Canadian facility. Richard Paige's arithmetic check got a triple affirmative. That is not a division any more; it is a product line. And in its place, a genuinely new vocabulary has appeared. Warhead shows up in the company's keyword history for the first time, alongside energetics: “we have over 100 real experts in the field of energetics and warheads... but we've chosen strategically to look at moving that into volume manufacturer of small form factor warheads” — Steve Wadey, Chief Executive Officer · 2026-11-12. Add HELENA directed-energy lasers, more than GBP 20m of committed investment, and the Project Safari overhaul of test and evaluation, and you have a company trying to slide from services provider to sovereign product manufacturer — the only route to a margin that isn't set by a government auditor. The political geography has narrowed to two words that now top the company's keyword list: key allies and European NATO. The UK defence investment plan commits GBP 68bn this year growing 5% for three, and management puts the addressable market at GBP 13bn a year, GBP 6bn of it domestic, against a pipeline north of GBP 12bn over five years. Whether that is a strategy or a slogan depends entirely on execution.The tape has stopped paying for rearmament
Here is the tension the presentation cannot resolve. QinetiQ is concentrating its entire future into defence services at precisely the moment the equity market has been selling them. Over 90 days, the global theme tape shows Air Defense Systems among the sharpest decliners, dragging DRS, KTOS, Rheinmetall and RTX; the flight test program complex around AAV, ACHR, JOBY and BETA has been a persistent loser across a full year. Defence-tech valuations have been compressing even as budgets went up. What is being bought is narrower and stranger. The 30-day advancers include space based interceptors — BAH, FLY, NOC, LMT, LHX — and the fresh defence stories reporting this week cluster around small drones and counter-UAS, with both DPRO and FLT.TO flagging the Defence Drone Initiative and the Canadian Armed Forces in the same breath. That read-across matters for QinetiQ, whose counter-drone laser work is precisely in that lane — but the company buries it in R&D language rather than leading with it, and the market has not made the connection.Ambition in the prose, prudence in the numbers
Charles Armitage put the question everyone in the room was circling: if UK defence rises 5% nominal and you add digital targeting web, mission data into Europe and the rest, how is 5% growth anything but a share loss?He got two "another guidance question" jokes and a stone wall. The rebuff is now a familiar ritual. In May, Martin Cooper insisted “our sights are at much higher than the numbers you articulated” — Martin Cooper, Group Finance Director · 2026-05-21; this week he offered “we don't lack ambition to grow at much higher levels, and we think we have the opportunity pipeline to do that” — Martin Cooper, Chief Financial Officer · 2026-11-12 — before guiding to 4-6% revenue, an 11.5-12% margin, ~90% cash conversion and 8-10% EPS growth. Three calls, same pattern: soaring rhetoric in the Q&A, sober arithmetic in the slides. Believe the arithmetic.To me, you've talked -- well, you talked about growth a lot. And to me, growth is growing faster than your markets... but 5% sort of seems to be going backwards.